Reviewed by Joel Scanlon
After facing terminal illness, a patient with idiopathic multicentric Castleman’s disease defied the odds thanks to an AI-driven drug discovery. This groundbreaking research showcases how artificial intelligence can uncover new treatments for rare and life-threatening conditions.